Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives. | Cancers (Basel) | 2021 | 33562653 | PubTator, text mining | PubMed |
| Syndecan receptors: pericellular regulators in development and inflammatory disease. | Open Biol | 2021 | 33561383 | PubTator, text mining | PubMed |
| Evaluation of quasi-static and dynamic nanomechanical properties of bone-metastatic breast cancer cells using a nanoclay cancer testbed. | Sci Rep | 2021 | 33542384 | PubTator, text mining | PubMed |
| SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance. | Elife | 2021 | 33527896 | PubTator, text mining | PubMed |
| Src-family Protein Tyrosine Kinases: A promising target for treating Cardiovascular Diseases. | Int J Med Sci | 2021 | 33526983 | PubTator, text mining | PubMed |
| The structure and function of protein kinase C-related kinases (PRKs). | Biochem Soc Trans | 2021 | 33522581 | PubTator, text mining | PubMed |
| Platinum Nanoparticles Enhance Exosome Release in Human Lung Epithelial Adenocarcinoma Cancer Cells (A549): Oxidative Stress and the Ceramide Pathway are Key Players. | Int J Nanomedicine | 2021 | 33519199 | PubTator, text mining | PubMed |
| Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. | Arch Toxicol | 2021 | 33512557 | PubTator, text mining | PubMed |
| Proteolytic Processing of CD44 and Its Implications in Cancer. | Stem Cells Int | 2021 | 33505471 | PubTator, text mining | PubMed |
| Myosin II and Arp2/3 cross-talk governs intracellular hydraulic pressure and lamellipodia formation. | Mol Biol Cell | 2021 | 33502904 | PubTator, text mining | PubMed |
| KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion. | J Cell Mol Med | 2021 | 33486887 | PubTator, text mining | PubMed |
| Autophagy regulation by acetylation-implications for neurodegenerative diseases. | Exp Mol Med | 2021 | 33483607 | PubTator, text mining | PubMed |
| Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer. | Breast Cancer Res Treat | 2021 | 33474679 | PubTator, text mining | PubMed |
| Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC). | Cancers (Basel) | 2021 | 33466719 | PubTator, text mining | PubMed |
| Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis. | Medicine (Baltimore) | 2021 | 33466191 | PubTator, text mining | PubMed |
| Formin homology domains of Daam1 bind to Fascin and collaboratively promote pseudopodia formation and cell migration in breast cancer. | Cell Prolif | 2021 | 33458919 | PubTator, text mining | PubMed |
| The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma. | Int J Mol Sci | 2021 | 33451139 | PubTator, text mining | PubMed |
| Downregulation of FHOD1 Inhibits Metastatic Potential in A549 Cells. | Cancer Manag Res | 2021 | 33447082 | PubTator, text mining | PubMed |
| Distribution of cortactin in cerebellar Purkinje cell spines. | Sci Rep | 2021 | 33446758 | PubTator, text mining | PubMed |
| UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex. | Cell Stem Cell | 2021 | 33417871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=61